251010 | 1-β-D-Arabinofuranosylcytosine - CAS 147-94-4 - Calbiochem

251010
No pudo obtenerse el precio
Minimum Quantity needs to be mulitiple of
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    Remaining : Will advise
      Se avisará
      Ver precios y disponibilidad
         CompararClick To Print This Page

      Overview

      Replacement Information

      Tabla espec. clave

      Empirical Formula CAS #
      C₉H₁₃N₃O₅ 147-94-4

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      251010-1GM
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        Remaining : Will advise
          Se avisará

          1 gm
          Recuperando precio...
          No pudo obtenerse el precio
          Minimum Quantity needs to be mulitiple of
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          Overview Anticancer, antiviral agent that is especially effective against leukemias. Induces apoptosis in human myeloid leukemia cells and in rat sympathetic neurons. Induces G1/S phase cell cycle arrest.
          Catalogue Number 251010
          Brand Family Calbiochem®
          Synonyms Ara-C, Cytarabine, Cytosine Arabinoside
          References
          References Zarilli, R., et al. 1999. Gastroenterology 116, 1358.
          Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
          Grant, S., et al. 1994. Oncol. Res. 6, 87.
          Greenberg, A.L., et al. 1994. Cancer 74, 1261.
          Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
          Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
          Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
          Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
          Este, E., et al. 1992. Blood 79, 2246.
          Owens, J.K., et al. 1992. Cancer Res. 52, 2389.
          Product Information
          CAS number 147-94-4
          ATP Competitive N
          Form White solid
          Hill Formula C₉H₁₃N₃O₅
          Chemical formula C₉H₁₃N₃O₅
          Molar Mass 243.2
          Reversible N
          Structure formula Image
          Applications
          Biological Information
          Primary Target Anticancer, antiviral agent that is especially effective against leukemias
          Physicochemical Information
          Cell permeable N
          Solubility H₂O
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECS HA5425000
          Safety Information
          R Phrase R: 20/21/22-36/37/38-43-61

          Harmful by inhalation, in contact with skin and if swallowed.
          Irritating to eyes, respiratory system and skin.
          May cause sensitization by skin contact.
          May cause harm to the unborn child.
          S Phrase S: 22-36-45

          Do not breathe dust.
          Wear suitable protective clothing.
          In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Harmful & Carcinogenic / Teratogenic
          Storage +2°C to +8°C
          Do not freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Title

          Material Safety Data Sheet (MSDS)  

          Certificados de análisis

          CargoNúmero de lote
          251010

          Referencias bibliográficas

          Visión general referencias
          Zarilli, R., et al. 1999. Gastroenterology 116, 1358.
          Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
          Grant, S., et al. 1994. Oncol. Res. 6, 87.
          Greenberg, A.L., et al. 1994. Cancer 74, 1261.
          Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
          Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
          Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
          Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
          Este, E., et al. 1992. Blood 79, 2246.
          Owens, J.K., et al. 1992. Cancer Res. 52, 2389.
          Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision 30-April-2008 RFH
          Synonyms Ara-C, Cytarabine, Cytosine Arabinoside
          Description Cytosine analog that acts as a potent inhibitor of eukaryotic cellular and viral replicative DNA synthesis. AraCTP, formed by intracellular phosphorylation of AraC, is utilized as a substrate by DNA polymerases, which incorporate AraCMP residues into DNA. Incorporated 3'-terminal AraCMP residues inhibit further DNA synthesis by impeding chain elongation by DNA polymerase. AraC is used clinically in the treatment of various cancers, particularly leukemias and lymphomas. Also used to inhibit proliferation of cultured cells and replication of eukaryotic viruses (e.g. vaccinia virus, herpes simplex virus). Also shown to induce apoptosis in human myeloid leukemia cells and in post-mitotic rat sympathetic neurons.
          Form White solid
          CAS number 147-94-4
          RTECS HA5425000
          Molar mass 243.2
          Chemical formula C₉H₁₃N₃O₅
          Structure formula
          Solubility H₂O (1 mM)
          Storage +2°C to +8°C
          Do Not Freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Toxicity Harmful & Carcinogenic / Teratogenic
          Merck USA index 14, 2784
          References Zarilli, R., et al. 1999. Gastroenterology 116, 1358.
          Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
          Grant, S., et al. 1994. Oncol. Res. 6, 87.
          Greenberg, A.L., et al. 1994. Cancer 74, 1261.
          Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
          Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
          Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
          Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
          Este, E., et al. 1992. Blood 79, 2246.
          Owens, J.K., et al. 1992. Cancer Res. 52, 2389.